Skip to contentB
Bio-Path Holdings, Inc.
B
BPTHBio-Path Holdings, Inc. Q2 2014 · 10-Q
Revenue$0.00$0.00— vs Q2 2013 Net Income-$1.27M-$1.27MN/M vs Q2 2013 EPS Diluted-$0.01-$0.01N/M vs Q2 2013 Operating Income-$1,274,801N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Path Holdings, Inc. · CIK 1133818 · Engraved from SEC EDGAR
derived
ended Jun 30, 2014 · filed Aug 14, 2014 · 45 d after period end